-
BiondVax Reports Positive Phase 2b Clinical Trial Results for Universal Flu Vaccine
americanpharmaceuticalreview
July 21, 2017
BiondVax Pharmaceuticals and the UNISEC consortium reported statistically significant positive results from the Phase 2b clinical trial of M-001, BiondVax's universal flu vaccine candidate.
-
Could a MenB vaccine protect against gonorrhea? GSK wants to find out
fiercepharma
July 14, 2017
Health authorities using a meningitis B shot in a mass vaccination campaign in New Zealand recently found a joyfully surprising byproduct—the vaccine might also offer protection against gonorrhea. Now, GlaxoSmithKline is planning to explore the potential
-
Merck moves up sales rankings in vaccine industry projection
fiercepharma
July 05, 2017
Last year, life science commercial intelligence firm Evaluate released a vaccine market projection stating that GlaxoSmithKline would top the industry by 2022, with Sanofi, Pfizer and Merck trailing in order.
-
Major advancement in cell-based influenza vaccine technology by Seqirus
biospectrumasia
June 26, 2017
Seqirus has successfully produced cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs
-
Florida congressional members want U.S. Army to hold public hearings on Zika vaccine
newsnow
June 15, 2017
Florida congressional members want U.S. Army to hold public hearings on Zika vaccine.
-
Cancer vaccine developer Targovax pulls in €21M in private placement
fiercepharma
June 14, 2017
Norwegian biotech Targovax has raised about €21 million in a private placement as it works to advance prostate cancer vaccine TG01 and other programs against a variety of cancers.
-
Vaccine Blocks Drug Heroin High in Tests on Monkeys
drugs
June 08, 2017
a vaccine designed to block a heroin "high" worked in monkeys
-
Vaccine Blocks Drug Heroin High in Tests on Monkeys
drugs.com
June 08, 2017
A vaccine designed to block a heroin "high" worked in monkeys, which could open the door to human clinical trials, researchers say.
-
Vetter, Microdermics Enter Strategic Drug Delivery Alliance
contractpharma
June 01, 2017
To develop microneedle drug delivery systems
-
Shareholder suit targets NewLink management over failed cancer vaccine trial
fiercepharma
May 25, 2017
A year after NewLink Genetics reported a phase 3 trial failure for its pancreatic cancer vaccine that crushed shares, a shareholder is taking it to the company’s current and former execs for “gross mismanagement” and other allegations.